Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BNTC | US
0.27
3.17%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
8.63
8.77
8.77
8.36
Benitec Biopharma Inc. a development-stage biotechnology company focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301 an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
38.5%1 month
37.5%3 months
74.6%6 months
98.2%-
-
7.15
0.03
0.02
0.27
9.77K
-
-21.41M
86.99M
86.99M
-
-307.03K
-
12.50
-267.59
3.00
0.82
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.18
Range1M
1.30
Range3M
5.14
Rel. volume
0.92
Price X volume
127.05K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.7391 | 92.15M | 0.35% | n/a | -148.05% |
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 1.86 | 85.12M | 0.00% | n/a | 41.98% |
Silver Spike Investment Corp. Common Stock | SSIC | Drug Manufacturers-Specialty & Generic | 11.6 | 72.09M | 0.96% | 12.64 | 0.00% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.63 | 61.71M | 3.82% | n/a | 25.73% |
Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 4.27 | 55.33M | -0.23% | 5.07 | 27.85% |
Qilian International Holding Group Limited | QLI | Drug Manufacturers-Specialty & Generic | 8.08 | 48.23M | 1.00% | n/a | 1.35% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.37 | 42.52M | 1.48% | n/a | 318.92% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.0899 | 37.75M | 1.01% | n/a | 0.00% |
Cannex Capital Holdings Inc | ARRXF | Drug Manufacturers-Specialty & Generic | 0.1318 | 33.72M | n/a | 0.50% | |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3487 | 26.37M | 2.56% | n/a | 4.33% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Culp Inc | CULP | Textile Manufacturing | 6.35 | 79.31M | 5.31% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 5.78 | 62.58M | -6.47% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.04 | 18.78M | 13.06% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 12.43M | -7.27% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.737 | 11.34M | 3.80% | n/a | 422.08% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6475 | 6.16M | -2.76% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.315 | 4.97M | -1.56% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.42 | 3.63M | 1.43% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.751 | 1.10M | 24.54% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 915.21K | -8.33% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.27 | 16.67 | Cheaper |
Ent. to Revenue | 9,773.27 | 309.37 | Expensive |
PE Ratio | - | 29.14 | - |
Price to Book | 7.15 | 12.81 | Cheaper |
Dividend Yield | - | 2.80 | - |
Std. Deviation (3M) | 74.57 | 75.12 | Par |
Debt to Equity | 0.03 | -0.93 | Expensive |
Debt to Assets | 0.02 | 0.45 | Cheaper |
Market Cap | 86.99M | 5.22B | Emerging |